News from hospira, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 19, 2014, 16:30 ET

Hospira to Present at the J.P. Morgan 33rd Annual Healthcare Conference Jan. 14, 2015

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will...

Dec 19, 2014, 14:45 ET
Hospira Foundation announces The Leukemia & Lymphoma Society as winner of $100,000 (Mission: Care)2 grant.

Hospira Foundation Announces The Leukemia & Lymphoma Society as Winner of $100,000 (Mission: Care)2 Grant

 The Hospira Foundation, the philanthropic arm of Hospira, Inc., today announced that The Leukemia & Lymphoma Society (LLS) was selected...

Dec 02, 2014, 15:51 ET
Hospira Foundation announces 10 recipients of (Mission: Care)2 Grant Challenge and launches video contest to decide winner of an additional $100,000 grant.

Hospira Foundation Announces 10 Recipients of (Mission: Care)2 Grants and Initiates Next Phase of Challenge

 The Hospira Foundation, the philanthropic arm of Hospira, Inc., today announced the 10 recipients of the initial grants for (Mission: Care)2,...

Nov 17, 2014, 10:30 ET

Hospira Mourns Passing of Founding Board Member Dr. Connie R. Curran

 The board of directors and employees of Hospira, Inc. (NYSE: HSP)  today expressed their deepest sorrow over the loss of Connie  R....

Nov 06, 2014, 07:30 ET

Hospira Reports Third-Quarter 2014 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the third...

Nov 05, 2014, 16:08 ET

Hospira Announces U.S. Launch of Generic Paricalcitol Injection

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol...

Oct 06, 2014, 10:30 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira to Host Conference Call for Third-Quarter 2014 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss...

Oct 02, 2014, 15:39 ET
Apply now for the 2014 Hospira Foundation Grant Challenge online at Hospira.com/MissionCare2. (PRNewsFoto/The Hospira Foundation)

Hospira Foundation Announces Launch of (Mission: Care)2 Grant Challenge in Honor of 10th Anniversary

 The Hospira Foundation, the philanthropic arm of Hospira, Inc., today announced the launch of (Mission: Care)2, the 2014 Hospira Foundation...

Aug 15, 2014, 13:00 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira to Present at the Morgan Stanley Global Healthcare Conference

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will...

Jul 30, 2014, 07:30 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira Reports Second-Quarter 2014 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the second...

Jul 25, 2014, 06:06 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

El biosimilar Retacrit™ demuestra ser efectivo en la anemia inducida por quimioterapia

- Nueva publicación en BMC Cancer con los resultados del estudio ORHEO: El biosimilar Retacrit™, efectivo en la anemia inducida por...

Jul 24, 2014, 21:31 ET
Jul 24, 2014, 15:37 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Biosimilar Retacrit™ wirksam bei chemotherapeutisch induzierter Anämie - Neue Veröffentlichung von ORHEO-Studienergebnissen in BMC Cancer

- Daten von über 2.300 Patienten in großer Post-Marketing-Beobachtungs-ORHEO-Studie sind jetzt online verfügbar Hospira (NYSE:...

Jul 04, 2014, 14:09 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira Completes Acquisition of Orchid's Active Pharmaceutical Ingredient Manufacturing and R&D Facility

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the...

Jul 01, 2014, 10:48 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira to Host Conference Call for Second-Quarter 2014 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss...

Jun 17, 2014, 16:26 ET
May 07, 2014, 12:45 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira Convenes Its 2014 Annual Meeting of Shareholders

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today held its 2014 Annual Meeting of...

Apr 30, 2014, 07:30 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira Reports First-Quarter 2014 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the first...

Apr 28, 2014, 19:08 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira presenta los resultados de PASCO I para Biosimilar Retacrit™/Silapo® en anemia renal

- Hospira presenta resultados de PASCO I (estudio observacional de cohorte de seguridad post-autorización) para Biosimilar...

Apr 28, 2014, 17:42 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira stellt Ergebnisse von PASCO I (Post-Authorization Safety Cohort Observational Study) zu Biosimilar Retacrit™/Silapo® bei Patienten mit renaler Anämie vor

Hospira (NYSE: HSP), der weltweit führende Anbieter von injizierbaren Medikamenten und Infusionstechnologien teilte letzte Woche die...